As the co-occurrence of APOE4 and a FH of AD has shown synergistic effects on Aβ deposition and cerebral glucose metabolism [28], we further expect collective effects of both AD risk factors on rT1w/T2w ratio levels and rs-FC patterns. The gene discussed is APOE; the disease is Alzheimer disease.